what to avoid when taking semaglutide Foods Wegovy: To Eat and Skip for Better Results What Not To Eat When
Description
In Phase 2 clinical trials, 88.8% of patients successfully tolerated treatment through 48 weeks
Semaglutides ability to aid in weight reduction and metabolic improvement naturally extends to enhancing cardiac health
According to the STEP 1 trial, the average weight loss at 68 weeks was 14.9% of body weight [1] on the 2.4mg maintenance dose
However, native GLP-1 is always easily degraded by dipetidylpeptidase IV (DPP IV) to produce some N-terminally truncated metabolites in vivo, followed by rapid clearance (half-life is around 2 min), preventing its broad applications 8
